Predict your next investment

HEALTHCARE | Pharmaceutical Distribution & Wholesale
nuscriptrx.com

See what CB Insights has to offer

Stage

Series D - II | Alive

Total Raised

$44.95M

Last Raised

$3.85M | 7 yrs ago

About NuScriptRX

ND Acquisitions Corp., dba NuScriptRX, formerly New Day Pharmacy, is an institutional pharmacy that serves the pharmaceutical needs of long-term care facilities and patients. The company packages and delivers medications to long-term care facilities and their patients after receiving orders from physicians.

NuScriptRX Headquarter Location

5215 Linbar Drive Suite 210

Nashville, Tennessee, 37211,

United States

866-395-9476

Latest NuScriptRX News

NuScriptRX Closes $5 Mln in Series C Add-On

Aug 28, 2012

NuScriptRX Closes $5 Mln in Series C Add-On August 27, 2012 Follow @luisarbeltran NuScriptRX received $5 million in Series C add-on led by Council Capital and its TNInvestco arm, Council & Enhanced Tennessee Fund. Existing investors in the Series C round include Clayton Associates of Nashville, Tenn., Council Operating Partner Linwood A. (Chip) Lacy Jr. and Envest of Virginia Beach, Va. Nashville-based NuScriptrx is a mail order institutional pharmacy. PRESS RELEASE NuScriptRX, the Nashville-based mail order institutional pharmacy, has closed on a $5 million Series C add-on led by Council Capital and its TNInvestco arm, Council & Enhanced Tennessee Fund. In addition to Council Capital and the Tennessee Fund, the Series C round includes other existing investors: Clayton Associates of Nashville, Tenn., Council Operating Partner Linwood A. (Chip) Lacy, Jr., Envest of Virginia Beach, Va., three other TNInvestco funds – Nest-TN of Tullahoma, Tenn., Tennessee Angel Fund of Nashville, Tenn. (an affiliate of Nashville Capital Network) and Innova of Memphis, Tenn., and an additional unnamed strategic investor. “This new capital will allow NuScriptRX  to sustain the strong momentum it is currently enjoying while also building the infrastructure and operational excellence to manage the growth,” said Dennis Bottorff, chairman of the NuScriptRX board of directors and Managing General Partner of Capital Council.”With the growth in the elderly population and increasing dissatisfaction with the cost and quality of service from the current pharmacy model, NuScriptRX is clearly on the right side of change in healthcare.” The company, which has quadrupled its revenue run-rate to over $30 million in the past 18 months, uses automated dispensing systems to improve productivity and administration of prescriptions through its single location in Nashville. NuScriptRX last week announced a new management team led by acting CEO Donald B. Taylor, a NuScriptRX board member and member of Council Capital’s CEO Council, and Jim Beaumariage, a 25-year veteran in pharmacy and healthcare management. “As a company with investments from four TNInvestco companies, NuScriptRX is a great example of delivering on the 2009 state legislation intended to jump start job creation in sectors of the economy with high growth potential. NuScriptRX has created over 60 Tennessee jobs, more than any other TNInvestco company, and has nearly doubled the size of its Nashville central pharmacy,” said Council Capital’s Rick Apple, new director of the Tennessee Fund. About NuScriptRX NuScriptRx is able to reduce cost while improving medication access without the geographic limitations of the traditional courier-based delivery model. By deploying its’ proprietary eMed-StatTM  and PharmComTM medication access and communications technologies, NuScriptRX provides timely, cost-effective and safer administration of medicines to long-term care nursing facilities in eight states from one pharmacy center in Nashville,Tenn. This enables the company to provide a higher level of service while saving customers money through reduced drug waste and improved access to medication 24 hours a day, 7 days a week. Additional information on NuScriptRX can be accessed at www.nuscriptrx.com. © 2015 Buyouts Insider / Argosy Group LLC

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing NuScriptRX

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NuScriptRX is included in 1 Expert Collection, including Pharma Supply Chain.

P

Pharma Supply Chain

1,258 items

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.